Irish Medical TimesPrediction models 'are not crystal balls'Irish Medical TimesIn his latest clinical update, Gary Culliton examines tools which help establish the level of risk for acute heart failure and also the role of the newly-evolved bio…
San Francisco ChroniclePear or heart-shaped, yellow, pink or clear: Big diamonds find wealthy buyers …Calgary HeraldThe 76.02 carat diamond, with perfect colour and internally flawless clarity, came from the ancient Golconda mines in India. Its value…
Azathioprine, methotrexate perform similarly with infliximab in biologic-naive …HealioLAS VEGAS — Biologic-naive patients with IBD who treated with infliximab and received methotrexate as an adjuvant therapy experienced similar outcomes to those wh…
Joe Brolly: "There was no rejection as we understand it. It was all the more agonising for that." All-Ireland-winning footballer and RTÉ analyst Joe Brolly has spoken of the devastation he suffered on hearing his kidney donation to a friend …
Hartlepool MailMessages to raise organ donor awarenessHartlepool MailNational Blood and Transplant, which is responsible for organ, blood and tissue donation, asked every trust in the country to set up an organ donation committee to raise awareness and…
Immunovative, Inc. has today announced that Immunovative Therapies, Ltd. and The University of Arizona Cancer Center and The University of Arizona Medical Center have agreed to expand their current collaboration …
First liver cancer 'chemo-bath' in the UKBusiness StandardFirst liver cancer 'chemo-bath' in the UK. Press Trust of India / London November 13, 2012, 17:25. British doctors have managed to bathe the livers of two patients with chemother…
Arrowhead Research Corporation , a targeted therapeutics company, announced today that prominent hepatologist Robert G. Gish, MD, will serve as Chairman of the company’s newly created hepatitis B Clinical Advisory Board.
World's first liver cancer 'chemo-bath' takes place in UKNewstrack IndiaLondon, Nov. 13 (ANI): A "chemo-bath" which delivers toxic cancer drugs to just one organ in the body has been used for the first time on patients in the UK. …
Clinical briefs from Novartis, Gilead and AstraZenecaThe Pharma LetterThe trial evaluated the introduction of Certican (everolimus) with reduced exposure tacrolimus administered twice-daily starting one month after liver transplantation versus standard…